Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Study of 99mTc-FAPI Quantitative SPECT/CT and 68Ga-FAPI PET/CT in Clinical Diagnosis and Staging of Gastrointestinal Tumors

NCT05444686 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT05444686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05444686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Study of 99mTc-FAPI Quantitative SPECT/CT and 68Ga-FAPI PET/CT in Clinical Diagnosis and Staging of Gastrointestinal Tumors
Lead sponsor
Xijing Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2022
Completion date
July 30, 2024
Enrollment
45 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

99mtc-fapi-positive gastrointestinal tumor